Clinical Trial Update: Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing rivaroxaban to warfarin in patients with metallic prostheses (prosthetic heart valves) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Heart Valve Disease
• Stroke
• Valve Heart Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Hospital Geral Roberto Santos | Conditions: Prostheses and Implants, Stroke | Phase 2, Phase 3 | Status: TERMINATED